Biotech vs COVID-19: The Role of Emerging Technologies in the Fight Against COVID-19 (Part 1)
Jun 4, 2020 ·
36m 51s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
This is part 1 of our event with BioIDEA: Biotech vs COVID-19 BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight...
show more
This is part 1 of our event with BioIDEA: Biotech vs COVID-19
BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19.
Our panelists included Elena Diez Cecilia, Director of Business Development and R&D Strategy at A2A Pharmaceuticals, Ed Painter, Chairman and CIO of A2A Pharmaceuticals; Peter Leonardi, CEO and Founder of OmniCyte; and our very own Andrew Satz, CEO and Co-Founder of EVQLV.
More from BioIDEA: bioidea.co/
More from A2A Pharmaceuticals: a2apharma.com/
More form OmniCyte: omnicyte.com/
More from EVQLV: evqlv.com/
show less
BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19.
Our panelists included Elena Diez Cecilia, Director of Business Development and R&D Strategy at A2A Pharmaceuticals, Ed Painter, Chairman and CIO of A2A Pharmaceuticals; Peter Leonardi, CEO and Founder of OmniCyte; and our very own Andrew Satz, CEO and Co-Founder of EVQLV.
More from BioIDEA: bioidea.co/
More from A2A Pharmaceuticals: a2apharma.com/
More form OmniCyte: omnicyte.com/
More from EVQLV: evqlv.com/
Information
| Author | Daniel Gigante |
| Organization | Daniel Gigante |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments